Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while revenue declined 6% from Rs 15,520 crore reported in the October-December quarter of FY26.
Info Edge reported a 22% year-on-year rise in Q4FY26 consolidated net profit to Rs 566 crore, driven by steady business growth. The operator of Naukri.com and Jeevansathi also posted a 16% increase in revenue to Rs 869 crore for the March quarter.
The US Federal Reserve is considering extending dollar swap lines with major global central banks to strengthen financial stability amid rising geopolitical risks, according to Reuters. Officials say longer-term liquidity arrangements could provide greater certainty to markets and reinforce the Fed’s role in supporting global funding systems during stress periods.
The Indian rupee strengthened to close above 96 per dollar for the first time in a week, following aggressive interventions by the Reserve Bank of India. The central bank sold billions of dollars and engaged in buy/sell swaps, pushing the rupee up despite rising crude oil prices. Analysts remain cautious, predicting potential further weakening if geopolitical tensions escalate.
The organised gold jewellery retail sector is set for a steep 13–15% volume decline to a decade low in FY27, driven by the government’s import duty hike to 15%. Rising prices, weaker affordability and a shift toward coins and bars are pressuring jewellery demand, warns Crisil.
Indian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative strength. Sector rotation is active, offering stock-specific opportunities in pharma, healthcare, energy, auto, and capital market-related stocks. Traders are advised to use range strategies and defined-risk options due to muted overall momentum.
Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future growth for the Indian healthcare sector. Key drivers include AI-led innovation, incremental advancements in niche areas, and improved quality culture. Attractive valuations also support this positive outlook for the industry.
MTAR Technologies shares jumped, extending a three-day rally to 24%, after the company secured a Rs 467.3 crore order from an international client. The firm said the deal is part of ongoing business with an existing customer, though the client’s name remains undisclosed due to confidentiality.
Indian equity markets show a mixed but improving consumption trend, with selective FMCG and premium retail outperforming. Page Industries is highlighted as a strong recovery story, while Nykaa and Honasa are viewed cautiously. The pharma sector continues its outperformance, with Sun Pharma and Aurobindo Pharma looking attractive.
Shares of One 97 Communications, the parent of Paytm, fell sharply on Friday after existing investors, including SAIF Partners and Elevation Capital, likely sold shares worth Rs 960 crore. Around 86 lakh shares changed hands in a large block deal, pressuring the stock despite broader market gains.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.